Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Innovate UK Awards Medherant a Medicines Manufacturing Grant

    Oct 3, 2018, 05:30 AM by Michael Croft
    COVENTRY, UK - Oct 3, 2018 - Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK
    Full story
  • The DNA Data Storage Machine That’s The Size Of A School Bus

    Oct 2, 2018, 10:50 AM by Michael Croft
    MIT Technology Review | A startup's concept drawing of a hulking device to archive data in DNA molecules shows the idea has a way to go.
    Full story
  • SynbiCITE launches new five-year strategy

    Oct 2, 2018, 09:39 AM by Michael Croft
    LONDON, UK - Oct 2, 2018 - SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources
    Full story
  • CRF Health, a CRF Bracket Company, Brings Industry Together to Lead Debate with eCOA Forum

    Oct 2, 2018, 08:58 AM by Michael Croft
    PLYMOUTH MEETING, PA - Oct 2, 2018 - CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today unveiled details of its 2018 eCOA Forum
    Full story
  • Knockout (KO) Validation

    Oct 2, 2018, 08:53 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Oct 2, 2018 - Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states
    Full story
  • Breakthrough Leukemia Treatment Backfires In A Rare Case

    Oct 1, 2018, 15:32 PM by Michael Croft
    The New York Times | A highly unusual death has exposed a weak spot in a groundbreaking cancer treatment: One rogue cell, genetically altered by the therapy, can spiral out of control in a patient and cause a fatal relapse.
    Full story
  • Bio-IT World Launches Innovative Practices Awards, Opens Call For Entries

    Oct 1, 2018, 07:40 AM by Michael Croft

    Bio-IT World | In 2019 Bio-IT World is launching the Innovative Practices Awards, an elite awards program designed to recognize partnerships and projects pushing our industry forward.

    Full story
  • Protein Dynamic Solutions recipient of NSF SBIR Phase IIB Supplemental award

    Sep 30, 2018, 18:45 PM by Michael Croft
    WAKEFIELD, MA - Oct 1, 2018 - Protein Dynamic Solutions (PDS) was awardeda Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) to focus on innovative breakthrough applications and commercialization of ProteinMentorTMplatform technology for pre-clinical candidate selection and to help ensure safety and efficacy of therapeutic proteins
    Full story
  • UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR

    Sep 28, 2018, 12:50 PM by Michael Croft
    BOSTON, MA - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programs
    Full story
  • Symbiosis secures FDA viral vector process approval

    Sep 27, 2018, 06:11 AM by Michael Croft
    NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 27, 2018 - Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK
    Full story
  • Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs

    Sep 27, 2018, 05:40 AM by Michael Croft
    MOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro  cardiac safety evaluation of new drugs
    Full story
  • Equus, Thermo Fisher Scientific, NVIDIA, And More: News From September 2018

    Sep 26, 2018, 12:55 PM by Michael Croft

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Equus, Thermo Fisher Scientific, NVIDIA, and more.

    Full story
  • Thermo Fisher Scientific Expands Genome Editing IP Portfolio

    Sep 26, 2018, 11:04 AM by Michael Croft
    CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio
    Full story
  • NIH-Funded Genome Centers To Accelerate Precision Medicine Discoveries

    Sep 26, 2018, 10:00 AM by Michael Croft

    Bio-IT World News Brief | The All of Us Research Program awarded funds totaling $28.6 million to establish three genome centers around the country.

    Full story
  • Qlucore AB announces changes to Board of Directors

    Sep 26, 2018, 09:54 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at Ericsson
    Full story
  • Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care

    Sep 26, 2018, 08:16 AM by Michael Croft
    PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients
    Full story
  • LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare

    Sep 25, 2018, 11:04 AM by Michael Croft
    CAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 -  Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reports
    Full story
  • Quanticate partners with CluePoints™ to offer Data Quality Oversight

    Sep 25, 2018, 04:31 AM by Michael Croft
    LONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the  amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines
    Full story
  • BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston

    Sep 24, 2018, 13:04 PM by Michael Croft
    WESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 a
    Full story
  • A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids Deadly Diseases

    Sep 21, 2018, 14:42 PM by Michael Croft
    Forbes | Amicus Therapertics is purchasing a portfolio of ten gene therapies for $100 million. But there's more to this story than most business deals.
    Full story
  • «
  • 261
  • 262
  • 263
  • 264 (current)
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy